 Home > Biochemistry News > Biotechnology News > Potential "first-in-class" allosteric activator received priority review qualification

Potential "first-in-class" allosteric activator received priority review qualification

 Last Update: 2021-09-05
 Source: Internet
 Author: User

Tags

rcvs treatment

iodine deficiency treatment

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Today, Agios Pharmaceuticals announced that the US FDA has accepted the new drug application (NDA) submitted by the company for mitapivat for the treatment of adult patients with pyruvate kinase (PK) deficiency

Pyruvate kinase deficiency is a rare genetic disease that manifests as chronic hemolytic anemia due to the accelerated destruction of red blood cells

Mitapivat is a potential "first-in-class" PKR allosteric activator

▲Mitapivat's potential mechanism of action (picture source: Agios official website)

This application is supported by two pivotal Phase 3 clinical trials, ACTIVATE and ACTIVATE-T

In December last year, Agios announced that mitapivat had also reached the primary endpoint in the Phase 3 clinical trial ACTIVATE in adult patients with pyruvate kinase deficiency who do not require regular blood transfusions

Reference materials:

[1] Agios Announces FDA Acceptance and Priority Review of New Drug Application for Mitapivat for Treatment of Adults with Pyruvate Kinase Deficiency.

(The original text has been deleted)

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.